Cleveland Clinic Cancer Advances
A Cleveland Clinic podcast for medical professionals exploring the latest innovative research and clinical advances in the field of oncology.
Episodes
288 episodes
Are We Missing Patients? Expanding Germline Genetic Testing in Oncology
As recommendations for germline genetic testing continue to expand, many eligible patients remain untested. In this episode of Cancer Advances, Demitrios Dedousis, MD, discusses current testing indications, common gaps in implementation and the...
Partnering with Classical Hematology: Optimizing Referrals, Diagnostics and Patient Care
Bethany Samuelson Bannow, MD, Director of Classical Hematology at Cleveland Clinic, joins the Cancer Advances podcast to discuss how stronger collaboration between oncologists, primary care physicians and classical hematologists can improve dia...
Personalizing Pediatric Cancer Care: The Promise of Precision Oncology
As molecular profiling advances, precision oncology is reshaping cancer care for children, adolescents and young adults. In this episode of Cancer Advances, Prajwal Rajappa, MD, MS, discusses how genomic sequencing, methylation profiling and mu...
From Evidence to Practice: How NCCN Defines the Standard of Cancer Care
What does it take to establish the standard of care in oncology? Matt Kalaycio, MD, Vice Chair of the Cleveland Clinic Cancer Institute and Chair of the National Comprehensive Cancer Network (NCCN) Board of Directors, joins the Cancer Advances ...
Redefining Resectability in Advanced Rectal Cancer
What happens when a cancer is deemed unresectable? In this episode, Dr. Haniee Chung discusses how multidisciplinary care is expanding treatment options for patients with advanced and recurrent rectal cancer. She highlights the role of tumor bo...
Preserving Vision, Expanding Options in Uveal Melanoma
As new therapies move through clinical trials, the management of uveal melanoma is entering a period of significant change. In this episode of Cancer Advances, Arun Singh, MD, discusses emerging strategies to avoid radiation, prevent radiation-...
Integrating Goals-of-Care Discussions in Oncology Practice
How can oncologists initiate meaningful goals-of-care discussions earlier in the disease course? In this episode, Dr. Natalie Jacobowski outlines practical communication strategies, including language, timing and approaches to reduce stigma and...
Building Smarter Testicular Cancer Data Sets with Large Language Models
How can better data improve decision-making in a curable but nuanced disease like testicular cancer? This episode explores how large language models can turn unstructured clinical notes into actionable insights, helping clinicians refine treatm...
Pre-Taxane Lutetium in Prostate Cancer: Changing the Treatment Algorithm
Is there a role for earlier integration of lutetium PSMA therapy in mCRPC management? Emerging evidence supports its use in the pre-taxane setting, prompting a shift in sequencing decisions. This episode outlines patient selection, PSMA imaging...
Rethinking "More Is Better": Deescalating Cancer Care
As cancer care becomes increasingly personalized, treatment deescalation is emerging as a key strategy to balance efficacy with quality of life. In this episode of Cancer Advances, Jame Abraham, MD, Enterprise Chair of Hematology and Medical On...
.jpg)
Using Dynamic Models to Inform Treatment and Prognosis in AML
How can we better predict progression and outcomes in a disease where treatment decisions must be made in days, sometimes hours? In this episode of Cancer Advances, Moaath Mustafa Ali, MD, MPH, discusses emerging longitudinal and evolutionary m...
Preserving Fertility During Pelvic Radiation: A Multidisciplinary Surgical Approach
Young patients requiring pelvic radiation face limited fertility preservation options. In this episode of Cancer Advances, Robert DeBernardo, MD, and Johanna Kelley, MD, both gynecologic oncologists at Cleveland Clinic, discuss uterine transpos...
.png)
Optimizing Treatment Decisions in Muscle-Invasive Bladder Cancer
Shilpa Gupta, MD, Genitourinary Medical Oncologist, joins the Cancer Advances podcast to explore how perioperative immunotherapy and ctDNA are redefining management of muscle-invasive bladder cancer. She reviews emerging phase III data and expl...
20 Years of Multidisciplinary Collaboration: Lessons from the Spine Tumor Board
Lilyana Angelov, MD, Neurosurgeon and Director of the Cleveland Clinic Gamma Knife Center, Samuel Chao, MD, Radiation Oncologist and Associate Director of the Gamma Knife Center; and Ajit Krishnaney, MD, Neurosurgeon in the Center for Spine Hea...
Advancing Care in Pediatric Neuro-Oncology
Amy Smith, MD, Pediatric Neuro-Oncologist, joins the Cancer Advances podcast to discuss recent progress in pediatric neuro-oncology. Listen as Dr. Smith explains the advances in tumor biology that are shaping treatment decisions and shares how ...
Adjustment Disorder in Patients with Cancer
Brian Barnett, MD, Director of the Cleveland Clinic Psychiatric Treatment Resistance Program, joins the Cancer Advances podcast to discuss adjustment disorder in patients with cancer. Dr. Barnett shares how oncologists can better recognize this...
Integrating Acupuncture into Cancer Care
Thuy Nguyen, DAOM, LAc, Section Head of Acupuncture for the Wellness ad Preventive Medicine Department at Cleveland Clinic, joins the Cancer Advances podcast discuss how acupuncture is being integrated into cancer care. Listen as she explains t...
Beyond 7+3: Redefining AML Treatment with Targeted Therapies and Trials
Director of the Inpatient Leukemia Unit, Anjali Advani, MD joins the Cancer Advances podcast to break down the latest acute myeloid leukemia clinical trials. From venetoclax-based regimens to emerging menin inhibitors and mutation-driven strate...
Cold EMR: Rethinking Polyp Resection Without Heat
Could removing heat improve safety in endoscopic mucosal resection? Florida Division Chair of the Department of Gastroenterology, Hepatology and Nutrition, and the Florida Region Director for Endoscopy, Tolga Erim, DO, joins the Cancer Advances...
.jpg)
Evolution of Neurofibromatosis and Schwannomatosis Care
Mina Lobbous, MD, MSPH, Neuro-Oncologist and Medical Director of the Adult Neurofibromatosis and Schwannomatosis Clinic at Cleveland Clinic, joins the Cancer Advances podcast to talk about the landscape of neurofibromatosis and schwannomatosis ...
Innovations Transforming Osteosarcoma Outcomes
The Cancer Advances Podcast welcomes back Nathan Mesko, MD, Vice Chair of Global Clinical Operations for the Department of Orthopaedic Surgery and Center Director for Musculoskeletal Oncology at Cleveland Clinic to talk about chemotherapy, limb...
Evolving Management in Classical Hematology
Bethany Samuelson Bannow, MD, Director of Classical Hematology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the evolving field of classical hematology and what it means for managing complex non-malignant blood diseases. Lis...
Optimizing Treatment Strategies in Inflammatory Breast Cancer
Julie Lang, MD, Breast Surgical Oncologist, joins the Cancer Advances podcast to discuss advancing care for patients with inflammatory breast cancer. Listen as Dr. Lang outlines key clinical features that distinguish IBC from infection, evidenc...
A National Tumor Board for DNA Repair and Telomere Biology Disorders
Associate Staff and Physician Scientist at Cleveland Clinic Children’s, Richa Sharma, MD, joins the Cancer Advances podcast to discuss the launch of a National DNA Repair and Telomere Biology Disorder Tumor Board. Listen as Dr. Sharma explains ...
.jpg)